| dc.contributor.author | Kong, Yi Wen | |
| dc.contributor.author | Dreaden, Erik C | |
| dc.date.accessioned | 2022-05-09T20:47:12Z | |
| dc.date.available | 2022-05-03T12:53:58Z | |
| dc.date.available | 2022-05-09T20:47:12Z | |
| dc.date.issued | 2022-04 | |
| dc.date.submitted | 2022-02 | |
| dc.identifier.issn | 2296-4185 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/142241.2 | |
| dc.publisher | Frontiers Media SA | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.3389/fbioe.2022.879988 | en_US |
| dc.rights | Creative Commons Attribution 4.0 International License | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | en_US |
| dc.source | Frontiers | en_US |
| dc.title | PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Kong, Yi Wen. 2022. "PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives." Frontiers in Bioengineering and Biotechnology, 10. | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | |
| dc.contributor.department | Center for Precision Cancer Medicine | |
| dc.relation.journal | Frontiers in Bioengineering and Biotechnology | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.date.submission | 2022-05-03T12:43:04Z | |
| mit.journal.volume | 10 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Authority Work Needed | en_US |
